All In Biotech

NDA 017512 · Vantive US Hlthcare

Dianeal Low Calcium W/Dextrose 4.25% In Plastic Container

Calcium Chloride, Dextrose, Magnesium Chloride, Sodium Chloride, Sodium Lactate · Intraperitoneal

Last checked: Nov 20, 2026Latest source record: Apr 16, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1978

Sep 27, 1978

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

8,165

7,325 serious, 3,950 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Apr 16, 2026.

DIANEAL peritoneal dialysis solutions are indicated for patients in acute or chronic renal failure. For management of acute or chronic renal failure.

Mechanism: DIANEAL peritoneal dialysis solutions are a pharmacologically inactive, hypertonic peritoneal dialysis solution containing dextrose, a monosaccharide, as the primary osmotic agent. An osmotic gradient must be created between the peritoneal membrane and the dialysis solution in order for ultrafiltration to occur. The hypertonic concentration of glucose in DIANEAL solutions exert an osmotic pressure across the peritoneal membrane resulting in transcapillary ultrafiltration. Like other peritoneal dialysis solutions, DIANEAL solutions contain electrolytes to facilitate the correction of...

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Sep 27, 1978 Original approval · Type 5 - New Formulation or New Manufacturer
15 products under this application
  • DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 18.3MG/100ML; DEXTROSE 4.25GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 1.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 18.3MG/100ML; DEXTROSE 2.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 2.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 3.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 2.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 1.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 2.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 18.3MG/100ML; DEXTROSE 3.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 4.25GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 18.3MG/100ML; DEXTROSE 1.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 1.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 3.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 4.25GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued
  • DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 4.25GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Discontinued

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • death1,362
  • peritonitis602
  • myocardial infarction510
  • cardiac failure congestive420
  • sepsis392
  • infection362
  • hypotension356
  • cardio-respiratory arrest349
  • acute myocardial infarction328
  • peritoneal dialysis complication320
  • pneumonia261
  • fluid overload229

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20111
201211
201319
20141,245
20152,786
20161,200
2017662
2018311
2019310
2020292
2021139
2022362
2023297
2024215
2025214
2026101

Recalls

9 FDA enforcement reports for this application.

  • Jun 17, 2024 · Class II · Ongoing

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.

  • Aug 11, 2023 · Class II · Terminated

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

  • Aug 11, 2023 · Class II · Terminated

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

  • Mar 15, 2023 · Class II · Completed

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

  • Mar 15, 2023 · Class II · Completed

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

  • Jan 2, 2019 · Class II · Terminated

    Lack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.

  • Aug 7, 2014 · Class I · Terminated

    Presence of Particulate Matter: particulate matter was found during the manufacturing process.

  • Feb 11, 2014 · Class I · Terminated

    Non-Sterility: Complaints of leaks and particulate matter identified as mold in the solution bag and the overpouch.

Shortages

FDA's drug shortage list.

  • To Be Discontinued · updated Aug 3, 2026

    DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0409-07). A business decision was made to discontinue...

  • To Be Discontinued · updated Aug 3, 2026

    DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-07). A business decision was made to discontinue manufacture of...

  • To Be Discontinued · updated Aug 3, 2026

    DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-07). A business decision was made to discontinue manufacture of...

  • To Be Discontinued · updated Aug 3, 2026

    DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-06). A business decision was made to discontinue manufacture of...

  • To Be Discontinued · updated Aug 3, 2026

    DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-06). A business decision was made to discontinue manufacture of...

  • To Be Discontinued · updated Aug 3, 2026

    DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0459-05). A business decision was made to discontinue...

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: Vantive US Hlthcare · Also marketed as Dianeal Pd-1 W/ Dextrose 1.5% In Plastic Container, Dianeal Low Calcium W/Dextrose 2.5% In Plastic Container, Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container, Dianeal Pd-2 W/ Dextrose 3.5% In Plastic Container, Dianeal 137 W/ Dextrose 2.5% In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.